You are viewing: Latin America Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The Latin America Latent TB Testing Market was valued at $31.4 Million in 2024 and projected to reach to $44.9 Million by 2029, representing a compound annual growth rate of 7.4%. Latin America's latent TB testing market is positioned for sustained growth through 2029, driven by escalating TB prevalence and strengthened healthcare systems.

Latin America Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Latin America Latent TB Testing Market Trends and Insights

  • Latin America's market expansion is driven by increasing TB prevalence, improved healthcare infrastructure, and rising awareness of latent tuberculosis infection screening.
  • The region's 7.4% compound annual growth rate outpaces global averages, reflecting strengthened public health initiatives and diagnostic adoption across Latin American countries. Latin America's latent TB testing landscape is characterized by growing investment in diagnostic technologies and preventive healthcare programs.
  • Between 2024 and 2029, Latin America is expected to see accelerated uptake of interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs) as healthcare systems prioritize early detection.
  • Latin America's market momentum is supported by government TB control programs, international funding, and partnerships with global health organizations focused on eliminating TB transmission in the region..

Key Market Statistics

  • CAGR (2024-2029) 7.4% CAGR
  • Market Size, 2024 ~USD 31.4 Million
  • Forecast, 2029 ~USD 44.9 Million
  • Geography Latin America

Latin America Latent TB Testing Market Overview

Strong Regional Growth Trajectory :

Latin America's latent TB testing market is expanding at 7.4% CAGR, significantly outpacing the global average of 5.8%, reflecting accelerating demand for diagnostic solutions across the region.

Rising TB Prevalence Driving Demand :

Increasing tuberculosis prevalence across Latin American countries is creating urgent need for latent TB infection screening programs, particularly in high-burden nations like Brazil and Mexico.

Healthcare Infrastructure Improvements :

Enhanced healthcare infrastructure and modernized diagnostic capabilities in Latin America are enabling wider adoption of latent TB testing technologies and screening initiatives.

Growing Awareness and Screening Programs :

Rising awareness of latent tuberculosis infection risks and government-backed screening programs are catalyzing market expansion and increasing testing adoption rates across the region.

Latin America Latent TB Testing Market Dynamics

  • The region's 7.4% CAGR reflects growing investment in diagnostic infrastructure and public health initiatives targeting latent TB detection.
  • Brazil and Mexico lead regional demand, supported by improved access to testing technologies and heightened clinical awareness. Government health policies and international TB control programs are accelerating screening adoption across Latin America.
  • The market expansion is further supported by rising healthcare spending, enhanced laboratory capabilities, and increasing collaboration between public and private healthcare providers.
  • These factors collectively position Latin America as a high-growth market for latent TB testing solutions through 2029..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Latin America's latent TB testing market is valued at $31.4 million in 2024 and will reach $44.9 million by 2029, growing at 7.4% CAGR.
    • Latin America's growth rate exceeds the global average, driven by increased TB burden and healthcare system modernization across the region.
    • Latin America is witnessing rising adoption of advanced diagnostic technologies including IGRAs and automated testing platforms.
    • Latin America's market expansion is supported by government TB elimination programs and international health partnerships.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    Latin America Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    Target Audience

    • Diagnostic Device Manufacturers : Manufacturers need Latin America market intelligence to identify expansion opportunities, assess competitive positioning, and develop region-specific latent TB testing solutions aligned with local healthcare standards.
    • Healthcare System Administrators : Hospital networks and public health authorities require market data to optimize TB screening program budgets, evaluate testing technologies, and plan infrastructure investments across Latin America.
    • In Vitro Diagnostics (IVD) Companies : IVD firms need regional market insights to guide product development, pricing strategies, and distribution partnerships for latent TB testing assays in high-growth Latin American markets.
    • Investment & Private Equity Firms : Investors evaluating healthcare opportunities in Latin America require detailed market forecasts and growth drivers to assess investment potential in TB diagnostics and related healthcare sectors.
    • Public Health & NGO Organizations : TB control programs and international health organizations need regional market data to allocate resources effectively, design screening initiatives, and measure progress toward TB elimination goals in Latin America.

    Latin America vs. other regions

    HowLatin America compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 239.8 Million · 2.8% wtd CAGR ·
    Europe
    ~USD 183.6 Million · 6.5% wtd CAGR ·
    Asia Pacific
    ~USD 298.7 Million · 8.1% wtd CAGR ·
    Middle East & Africa
    ~USD 6.4 Million · 5.7% wtd CAGR ·

    Countries within Latin America - compare and drill down

    Country2025 size (native)
    BrazilUSD 21 Million
    MexicoUSD 10.3 Million
    Rest Of Latin AmericaUSD 12.2 Million

    Country market size visualization

    Brazil
    USD 21 Million
    Mexico
    USD 10.3 Million
    Rest Of Latin America
    USD 12.2 Million

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Access precise market valuations for Latin America's latent TB testing sector with detailed 2024-2029 projections, enabling accurate business planning and investment decisions.
    • Country-Level Breakdown Analysis : Obtain granular market data for Brazil, Mexico, and Rest of Latin America, identifying high-opportunity markets and regional variations in testing adoption and healthcare spending.
    • Competitive Growth Intelligence : Benchmark Latin America's 7.4% CAGR against global trends (5.8%) to understand regional competitive advantages and market dynamics shaping the latent TB testing landscape.
    • Strategic Market Entry Insights : Leverage comprehensive regional analysis to develop targeted go-to-market strategies, identify key stakeholders, and prioritize Latin American markets for product launches and partnerships.
    • Healthcare Infrastructure & Policy Context : Understand Latin America's evolving healthcare infrastructure, TB screening programs, and regulatory environment to align solutions with regional clinical needs and market requirements.

    Frequently asked questions

    What is the current size of the latent TB testing market in Latin America?

    The latent TB testing market in Latin America was valued at $31.4 million in 2024 and is projected to grow to $44.9 million by 2029.

    What is the growth rate for latent TB testing in Latin America?

    Latin America's latent TB testing market is growing at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2029.

    What factors are driving growth in Latin America's latent TB testing market?

    Growth in Latin America is driven by rising TB prevalence, improved healthcare infrastructure, government TB control programs, and increased adoption of diagnostic technologies.

    Which diagnostic technologies are most commonly used in Latin America for latent TB testing?

    Latin America primarily uses interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs), with increasing adoption of automated and advanced diagnostic platforms.

    How does Latin America's market growth compare to global trends?

    Latin America's 7.4% CAGR exceeds the global average of 5.8%, reflecting stronger regional demand and healthcare investment in TB prevention and diagnosis.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status